Cell Guidance Systems’ nanoparticle cytokines enable use of macrophages to treat disease
Cell Guidance Systems Ltd, a specialist in the control, manipulation and monitoring of cells, both in vitro and in vivo, today announced its POlyhedrin Delivery System (PODS) technology has been shown to modulate macrophage secretion profiles with therapeutic potential. The results of this research are available as an unpublished preprint in bioRxiv1.
Budget 2021: Deloitte predictions
Ahead of the Chancellor’s Budget on 3 March 2021, Deloitte Cambridge Tax Partner Hannah Simoes and colleagues give their key predictions for the event. The UK’s regions continue as an expected area of focus in this Budget.
Demand for offices and laboratories are at an all-time high, being driven by knowledge-intensive industries
Bidwells' spring 2021 report reveals the second half of 2020 saw office and laboratory take up return to trend levels following a COVID-19 disrupted H1. Cambridge has been on the axis of the UK pandemic response sustaining business activity across the city. The take-up continues across various business sectors but dominated by knowledge-intensive industries.
First COVID-19 lockdown cost UK hospitality and high street £45 billion in turnover, researchers estimate
UK supermarkets and online retailers made an additional £4 billion each thanks to the coronavirus lockdown that began in March last year, according to econometric models.
Robotic dogs and laughter therapy: 10 ways to combat loneliness and isolation while social distancing
Robotic dogs, laughter therapy and mindfulness are some of the ways that might help people – particularly the elderly – cope with loneliness and social isolation while social distancing, say researchers at the University of Cambridge.
Velocix appoints Anthony Berkeley as CEO
Velocix, the market’s leading provider of carrier-grade video streaming and advertising technology, has announced the promotion of Anthony Berkeley to Chief Executive Officer.
New funding for national consortium to model COVID-19 pandemic
A national consortium including the University of Cambridge will bring together modellers to produce rigorous predictions for the COVID-19 pandemic to advise UK government bodies.
Thirteen more artists join Antony Gormley in supporting EACH
More works of art have been added to an exclusive online auction supporting East Anglia’s Children’s Hospices (EACH) - and the one-week countdown is now on!
Cambridge Is popular choice with buyers at international destination showcase
The official conference and events bureau for Cambridge was recently selected to participate in a prestigious international summit to connect with business meetings buyers from the UK, Europe, North America and China.
Hewitsons strengthens its residential practice with new appointment
Law firm Hewitsons is pleased to have further strengthened its residential property team with the appointment of licensed conveyancer Catherine Bolland, based predominately at the firm’s Cambridge office.
Paragraf listed as a key player by IDTechEx in CVD graphene for electronics applications
Paragraf has been listed as a key player in CVD grown graphene and the role this can have in the electronics sector by IDTechEx in its latest report – ‘Graphene Market & 2D Materials Assessment 2021-2031’.
Coronavirus contributing to blindness crisis in Zimbabwe: Cambridge charity launches appeal to help
Cambridge charity CBM is warning that hundreds of thousands of people are living needlessly blind in Zimbabwe – and the situation is worsening due to Coronavirus. CBM is launching a fundraising appeal today to improve access to sight-saving treatment and until 20 May all public donations will be doubled by the UK government.
Government’s Oxford-Cambridge Arc plan to help drive £20bn investment into region
As leading property advisor to the science and technology sector, Bidwells welcomes government moves announced today (18 February), that will help bring billions of pounds of funding for jobs, housing and infrastructure into the Arc’s knowledge economy.
University spin-out Cambridge GaN Devices raises $9.5m in Series A investment round
Cambridge GaN Devices (CGD) has raised $9.5 million in Series A funding. The investment was co-led by IQ Capital, Parkwalk Advisors, and BGF and joined by Cambridge Enterprise, Foresight Williams, Martlet Capital, Cambridge Angels, and Cambridge Capital Group. CGD will use the funding to expand its product portfolio of energy-efficient power devices and to double the size of its team.
Avacta announces phase 1 Clinical Trial Authorisation (CTA) for AVA6000 approved by MHRA
Cambridge and Wetherby, 18 February 2021: Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, announces that it has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) for its Clinical Trial Authorisation (CTA) in the UK for a phase I study of its lead pre|CISION™ pro-drug, AVA6000 pro-doxorubicin.
Xaar giving fund continues its support for local charities
Two charities have received £2000 each in donations from Xaar, the leading inkjet printing technology group, based on the Cambridge Science Park.
6G communications a trillion dollar opportunity, reveals IDTechEx
Phone systems change every ten years. 5G communications is now rolling out worldwide. It's time to plan 6G communications for 2030, says IDTechEx.
RxCelerate launches Galaxy™: a next-generation antibody discovery platform
RxCelerate, a leading international out-sourced drug discovery and development platform, today revealed details of a new antibody discovery platform, Galaxy™, that offers significant advantages over the current generation of tools for delivery of new therapeutic monoclonal antibodies.
Partnership helps transform Cambridge into a gigabit city
With UK adults now spending more than a quarter of their waking day online – the highest on record – the need for ultra-fast, ultra-reliable connectivity has never been stronger.
Intellegens and Ansys to empower additive manufacturing with material intelligence through machine learning
Machine learning specialist Intellegens and engineering simulation leader Ansys have announced a collaboration to integrate machine learning methods into Additive Manufacturing (AM) workflows, accelerating the development of reliable and repeatable AM processes.
Cheffins releases its inaugural Datapoint - an analysis of the laboratory, office and industrial sectors across the region
The Cheffins Datapoint research, just released, analyses rental values, take-up and availability across the laboratory, office and industrial sectors. The results illustrate that the coronavirus pandemic has had a long-reaching effect on the commercial property market.
Online conference reveals arts lessons from lockdown
Academics at Anglia Ruskin University (ARU) and the University of Cambridge will come together with practitioners in the creative arts sector to share learning about life under lockdown as part of the Cambridge Arts Network (CAN) conference, which is now taking place online until 4 March.
The Perfect Match: Finding the ideal fund finance solution partner
As the world went into lockdown in 2020, high-street lenders in the UK pulled back from commercial lending to focus on managing their existing loan books. OakNorth Bank saw this as an opportunity to put the pedal to the metal and support businesses at a time when many other lenders would be reluctant to do so.
Three Cambridge spin-outs join Centessa Pharmaceuticals, launched with a $250m Series A round
ApcinteX, Morphogen-IX, Z Factor join seven other privately held biotech companies in a new type of pharmaceutical R&D model.
Joyful Jane takes on 2 marathons, 2 half marathons and 100-mile bike ride for end of life care
“I never dreamed I could run a marathon but a friend of mine who helped me in the early days said if you never enter an event you will never achieve that goal. She was so right! If you train for something you want, you can achieve it.”